Lupin Limited (BOM:500257)
India
· Delayed Price · Currency is INR 2,302.10
-22.15 (-0.95%)
At close: Apr 28, 2026
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
10.89M INR
Profits / Employee
1.93M INR
Market Cap
1,052.47B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,811 |
| Torrent Pharmaceuticals | 17,059 |
| Abbott India | 3,659 |
| GlaxoSmithKline Pharmaceuticals | 3,113 |
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| AstraZeneca Pharma India | 600 |
| Granules India | 4,066 |
| Jubilant Pharmova | 5,547 |
Lupin News
- 7 days ago - Lupin launches Dapagliflozin and Metformin Extended-Release Tablets in the U.S. after FDA approval - Business Upturn
- 4 weeks ago - Lupin Receives Tentative U.S. FDA Approval For Sugammadex Injection - Nasdaq
- 4 weeks ago - Lupin receives tentative approval from U.S. FDA for Sugammadex Injection - Business Upturn
- 4 weeks ago - Lupin subsidiary Nanomi increases stake in Multicare Pharmaceuticals Philippines to 56.28% - Business Upturn
- 5 weeks ago - Lupin receives tentative U.S. FDA approval for Pitolisant Tablets - Business Upturn
- 5 weeks ago - Lupin announces expansion of Dabhasa manufacturing facility - Business Upturn
- 7 weeks ago - Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025 - Business Upturn
- 2 months ago - Lupin Goa facility clears US FDA inspection with VAI classification - Business Upturn